Prevalence and Risk Factors of Oral Mucositis in Paediatric Patients Undergoing Haematopoietic Stem Cell Transplantation

Overview

Journal Oral Dis

Specialty Dentistry

Date 2021 Jan 16

PMID 33453145

Citations 3

Authors

Abdulmalik Alhussain

Zikra Alkhayal

Mouhab Ayas

Hassan Abed

Affiliations

Soon will be listed here.

Abstract

Background: A complete understanding of oral mucositis (OM) is crucial to develop appropriate interventions to aid in the successful overall health outcome of paediatric patients undergoing haematopoietic stem cell transplantation (HSCT).

Aims: This study aimed at determining the prevalence and severity of OM and at identifying the predictive factors that might aggravate OM at one-week, two-week and three-week post-HSCT.

Methods: This retrospective, hospital-based study reviewed the medical records of 170 paediatric patients, summarising the patients' characteristics using descriptive statistics. Binary logistic regression was used to identify factors associated with the development of OM.

Results: At one-week post-HSCT, 41% of 140 patients (n = 49) had developed OM, this was reduced at two-week (n = 36, 33%) and three-week (n = 13, 19%) post-HSCT. Univariate logistic regression revealed that patients with cancer (OR = 0.16, 95% CI = 0.05-0.54; p-value = .003) had a significantly lower prevalence of OM. Younger patients with an average age of 7.9 years old (OR = 0.85, 95% CI = 0.75-0.97; p-value = 0.013) and the presence of GvHD (OR = 2.37, 95% CI = 1.03-5.45, p-value = 0.042) were significantly related to a higher prevalence of OM. Multivariable logistic regression confirmed that the risk of OM is lower in patients with cancer compared to those with immunodeficiency syndromes or hereditary blood diseases (OR = 0.18, 95% CI = 0.04-0.77; p-value = .021).

Conclusions: This study identified a significantly lower prevalence of OM in patients with cancer compared to other conditions and that young recipients and those who developed GvHD were more likely to have OM.

Citing Articles

Optimizing Autologous Stem Cell Transplantation in Multiple Myeloma: The Significance of Pre-Transplant Controlling Nutritional Status Score.

Ozkan S, Avci S, Kimiaei A, Safaei S, Altuntas Y, Yuksel Ozturkmen A Life (Basel). 2025; 15(2).

PMID: 40003698 PMC: 11856737. DOI: 10.3390/life15020289.

Influence of periodontal status on patients undergoing hematopoietic stem cell transplantation: A retrospective analysis.

Gao X, Zhao S, Wang S, Sun Y, Gao C Heliyon. 2024; 10(10):e30998.

PMID: 38778978 PMC: 11108988. DOI: 10.1016/j.heliyon.2024.e30998.

Oral Manifestations of Graft vs. Host Disease: A Comprehensive Review for Best Practice in Dentistry.

Miranda M, Gianfreda F, Carlotta D, Armati S, Barlattani A, Bollero P Medicina (Kaunas). 2023; 59(11).

PMID: 38003987 PMC: 10673022. DOI: 10.3390/medicina59111937.

Prevalence and risk factors of oral mucositis in paediatric patients undergoing haematopoietic stem cell transplantation.

Alhussain A, Alkhayal Z, Ayas M, Abed H Oral Dis. 2021; 28(3):657-669.

PMID: 33453145 PMC: 9291549. DOI: 10.1111/odi.13777.

References

Sonis S . The pathobiology of mucositis. Nat Rev Cancer. 2004; 4(4):277-84. DOI: 10.1038/nrc1318. View

Sonis S . Pathobiology of oral mucositis: novel insights and opportunities. J Support Oncol. 2007; 5(9 Suppl 4):3-11. View

Copelan E . Hematopoietic stem-cell transplantation. N Engl J Med. 2006; 354(17):1813-26. DOI: 10.1056/NEJMra052638. View

Vagliano L, Feraut C, Gobetto G, Trunfio A, Errico A, Campani V . Incidence and severity of oral mucositis in patients undergoing haematopoietic SCT--results of a multicentre study. Bone Marrow Transplant. 2010; 46(5):727-32. DOI: 10.1038/bmt.2010.184. View

Carreon-Burciaga R, Castaneda-Castaneira E, Gonzalez-Gonzalez R, Molina-Frechero N, Gaona E, Bologna-Molina R . Severity of Oral Mucositis in Children following Chemotherapy and Radiotherapy and Its Implications at a Single Oncology Centre in Durango State, Mexico. Int J Pediatr. 2018; 2018:3252765. PMC: 5971240. DOI: 10.1155/2018/3252765. View

Tomlinson D, Gibson F, Treister N, Baggott C, Judd P, Hendershot E . Challenges of mucositis assessment in children: expert opinion. Eur J Oncol Nurs. 2008; 12(5):469-75. DOI: 10.1016/j.ejon.2008.05.010. View

. Guideline on dental management of pediatric patients receiving chemotherapy, hematopoietic cell transplantation, and/or radiation. Pediatr Dent. 2013; 35(5):E185-93. View

Bowen J, Wardill H . Advances in the understanding and management of mucositis during stem cell transplantation. Curr Opin Support Palliat Care. 2017; 11(4):341-346. DOI: 10.1097/SPC.0000000000000310. View

Eduardo F, Bezinelli L, de Carvalho D, Marques da Graca Lopes R, Fernandes J, Brumatti M . Oral mucositis in pediatric patients undergoing hematopoietic stem cell transplantation: clinical outcomes in a context of specialized oral care using low-level laser therapy. Pediatr Transplant. 2015; 19(3):316-25. DOI: 10.1111/petr.12440. View

10.

Barriga F, Ramirez P, Wietstruck A, Rojas N . Hematopoietic stem cell transplantation: clinical use and perspectives. Biol Res. 2013; 45(3):307-16. DOI: 10.4067/S0716-97602012000300012. View

11.

Papas A, Clark R, Martuscelli G, OLoughlin K, Johansen E, Miller K . A prospective, randomized trial for the prevention of mucositis in patients undergoing hematopoietic stem cell transplantation. Bone Marrow Transplant. 2003; 31(8):705-12. DOI: 10.1038/sj.bmt.1703870. View

12.

Berger K, Schopohl D, Bollig A, Strobach D, Rieger C, Rublee D . Burden of Oral Mucositis: A Systematic Review and Implications for Future Research. Oncol Res Treat. 2018; 41(6):399-405. DOI: 10.1159/000487085. View

13.

Barasch A, Peterson D . Risk factors for ulcerative oral mucositis in cancer patients: unanswered questions. Oral Oncol. 2003; 39(2):91-100. DOI: 10.1016/s1368-8375(02)00033-7. View

14.

Abed H, Alhabshi M, Alkhayal Z, Burke M, Nizarali N . Oral and dental management of people with myelodysplastic syndromes and acute myeloid leukemia: A systematic search and evidence-based clinical guidance. Spec Care Dentist. 2019; 39(4):406-420. DOI: 10.1111/scd.12384. View

15.

Mubaraki S, Chandra Pani S, AlSeraihy A, Abed H, Alkhayal Z . The efficacy of two different oral hygiene regimens on the incidence and severity of oral mucositis in pediatric patients receiving hematopoietic stem cell transplantation: A prospective interventional study. Spec Care Dentist. 2020; 40(6):566-573. PMC: 7821098. DOI: 10.1111/scd.12525. View

16.

Farrington M, Cullen L, Dawson C . Assessment of oral mucositis in adult and pediatric oncology patients: an evidence-based approach. ORL Head Neck Nurs. 2010; 28(3):8-15. View

17.

Cinausero M, Aprile G, Ermacora P, Basile D, Vitale M, Fanotto V . New Frontiers in the Pathobiology and Treatment of Cancer Regimen-Related Mucosal Injury. Front Pharmacol. 2017; 8:354. PMC: 5462992. DOI: 10.3389/fphar.2017.00354. View

18.

Alhussain A, Alkhayal Z, Ayas M, Abed H . Prevalence and risk factors of oral mucositis in paediatric patients undergoing haematopoietic stem cell transplantation. Oral Dis. 2021; 28(3):657-669. PMC: 9291549. DOI: 10.1111/odi.13777. View

19.

Bardellini E, Schumacher F, Conti G, Porta F, Campus G, Majorana A . Risk factors for oral mucositis in children receiving hematopoietic cell transplantation for primary immunodeficiencies: a retrospective study. Pediatr Transplant. 2013; 17(5):492-7. DOI: 10.1111/petr.12094. View

20.

Sonis S . Oral mucositis. Anticancer Drugs. 2011; 22(7):607-12. DOI: 10.1097/CAD.0b013e3283462086. View